DermTech Correlations
| DMTK Stock | USD 0.61 0.01 0.97% |
The correlation of DermTech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as DermTech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if DermTech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Average diversification
The correlation between DermTech and NYA is 0.19 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding DermTech and NYA in the same portfolio, assuming nothing else is changed.
DermTech |
The ability to find closely correlated positions to DermTech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace DermTech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back DermTech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling DermTech to buy it.
Moving against DermTech Stock
| 0.86 | ELEV | Elevation Oncology Earnings Call This Week | PairCorr |
| 0.75 | VKTX | Viking Therapeutics Potential Growth | PairCorr |
| 0.73 | NRSNW | NeuroSense Therapeutics | PairCorr |
| 0.7 | XFOR | X4 Pharmaceuticals Earnings Call This Week | PairCorr |
| 0.54 | CGC | Canopy Growth Corp Trending | PairCorr |
| 0.53 | LLY | Eli Lilly Earnings Call This Week | PairCorr |
| 0.5 | BMY | Bristol Myers Squibb Earnings Call Today | PairCorr |
| 0.48 | ACB | Aurora Cannabis Trending | PairCorr |
| 0.43 | ELYM | Eliem Therapeutics | PairCorr |
| 0.77 | ACRV | Acrivon Therapeutics Financial Report 14th of May 2024 | PairCorr |
| 0.75 | OCEA | Ocean Biomedical | PairCorr |
Related Correlations Analysis
| 0.13 | -0.02 | -0.08 | 0.08 | 0.13 | ACRS | ||
| 0.13 | 0.71 | 0.33 | -0.52 | 0.69 | PRE | ||
| -0.02 | 0.71 | 0.4 | -0.74 | 0.45 | DRIO | ||
| -0.08 | 0.33 | 0.4 | -0.03 | 0.09 | OLK | ||
| 0.08 | -0.52 | -0.74 | -0.03 | -0.2 | STIM | ||
| 0.13 | 0.69 | 0.45 | 0.09 | -0.2 | FONR | ||
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between DermTech Stock performing well and DermTech Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze DermTech's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| ACRS | 2.77 | 0.16 | 0.01 | (0.24) | 3.35 | 6.78 | 21.90 | |||
| PRE | 4.15 | (0.04) | 0.03 | 0.07 | 5.02 | 12.28 | 33.17 | |||
| DRIO | 5.04 | (0.73) | 0.00 | (0.15) | 0.00 | 10.69 | 43.04 | |||
| OLK | 0.75 | (0.21) | 0.00 | (0.51) | 0.00 | 1.04 | 8.72 | |||
| STIM | 3.63 | 0.15 | 0.06 | 0.15 | 3.92 | 11.35 | 31.45 | |||
| FONR | 1.64 | (0.34) | 0.00 | (0.25) | 0.00 | 3.56 | 13.52 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in DermTech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Idea Analyzer Now
Idea AnalyzerAnalyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
| All Next | Launch Module |
DermTech Corporate Management
Elected by the shareholders, the DermTech's board of directors comprises two types of representatives: DermTech inside directors who are chosen from within the company, and outside directors, selected externally and held independent of DermTech. The board's role is to monitor DermTech's management team and ensure that shareholders' interests are well served. DermTech's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, DermTech's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Kevin MBA | Treasurer CFO | Profile | |
| Burkhard MD | Chief Officer | Profile | |
| Todd Wood | Chief Officer | Profile | |
| Daniel Visage | Senior Access | Profile | |
| Steven Stone | Senior Development | Profile | |
| Loren MD | Chief Officer | Profile | |
| JD Esq | General Counsel | Profile |
Already Invested in DermTech?
The danger of trading DermTech is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of DermTech is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than DermTech. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile DermTech is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether DermTech is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if DermTech Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Dermtech Stock. Highlighted below are key reports to facilitate an investment decision about Dermtech Stock: Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DermTech. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy DermTech Stock please use our How to buy in DermTech Stock guide.You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Complementary Tools for DermTech Stock analysis
When running DermTech's price analysis, check to measure DermTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DermTech is operating at the current time. Most of DermTech's value examination focuses on studying past and present price action to predict the probability of DermTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DermTech's price. Additionally, you may evaluate how the addition of DermTech to your portfolios can decrease your overall portfolio volatility.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |
Is DermTech's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DermTech. If investors know DermTech will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DermTech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.09) | Revenue Per Share 0.469 | Quarterly Revenue Growth 0.311 | Return On Assets (0.38) | Return On Equity (1.06) |
The market value of DermTech is measured differently than its book value, which is the value of DermTech that is recorded on the company's balance sheet. Investors also form their own opinion of DermTech's value that differs from its market value or its book value, called intrinsic value, which is DermTech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DermTech's market value can be influenced by many factors that don't directly affect DermTech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DermTech's value and its price as these two are different measures arrived at by different means. Investors typically determine if DermTech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DermTech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.